Resistell
Edit

Resistell

http://resistell.com/
Last activity: 28.03.2024
Active
Categories: AlternativeCultureDiagnosticsGrowthHardwareInformationLivingPlatformTechnologyTime
contact@resistell.com
Likes
115
Followers
115
Followers
946
Mentions
39
Location: Switzerland, Basel-Country, Muttenz
Employees: 11-50
Phone: +41 79 367 81 52
Total raised: $15.56M
Founded date: 2017

Investors 4

Funding Rounds 3

DateSeriesAmountInvestors
20.12.2022-$9.18M-
03.07.2020Grant$2.81M-
17.12.2019-$3.57M-

Mentions in press and media 39

DateTitleDescription
28.03.2024New additions to startups’ board of directors Trevor Hawkins joins Resistell’s Board of Directors, bringing 25 years of experience from his leadership roles across research, clinical, and corporate spheres globally. He has held several senior executive roles at Siemens Healthcare, Phi...
19.03.2024Resistell’s convincing study results published in Nature Communications Antimicrobial resistance (AMR) is a major public health threat, reducing treatment options for infected patients. AMR is promoted by a lack of access to rapid antibiotic susceptibility tests (ASTs). Accelerated ASTs can identify effective ...
07.09.2023A biotech company ranks first at the TOP 100 Swiss Startup Award
19.06.2023TechTour Growth Health showcases Swiss health solutions
07.03.2023First patients recruited for Resistell’s international clinical study
20.12.2022Resistell raises CHF8.5 million to bring its first product to the market
19.12.2022Resistell raises CHF 8.5 million to complete clinical trials for antibiotic susceptibility testing: interview with CEO Danuta CichockaResistell is a clinical-stage company with its own testing device developed by a highly skilled, cross-functional team of microbiologists, engineers, and data scientists. In April 2022, Resistell launched an R&D project to assess the ap...
19.12.2022Resistell raises CHF 8.5 million to complete clinical trials for antibiotic susceptibility testing: interview with CEO Danuta CichockaResistell raises CHF 8.5 million to complete clinical trials for antibiotic susceptibility testing: interview with CEO Danuta Cichocka 19.12.2022 16:30, Morgane Ghilardi linkedIn facebook twitter instagram youtube --> Resistell AG closed...
19.12.2022Resistell raises CHF 8.5 million to complete clinical trials for antibiotic susceptibility testing: interview with CEO Danuta CichockaResistell raises CHF 8.5 million to complete clinical trials for antibiotic susceptibility testing: interview with CEO Danuta Cichocka 19.12.2022 16:30, Morgane Ghilardi linkedIn facebook twitter instagram youtube --> Resistell AG closed...
26.04.2022Pfizer backs medtech startup Resistell
Show more

Reviews 0

Sign up to leave a review

Sign up Log In